as 07-05-2024 4:00pm EST
Aflac Inc offers supplemental health insurance and life insurance in United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling majority of its policies directly to consumers at their places of work and also reaches out to its customers out of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.
Founded: | 1955 | Country: | United States |
Employees: | N/A | City: | COLUMBUS |
Market Cap: | 49.8B | IPO Year: | N/A |
Target Price: | $83.50 | AVG Volume (30 days): | 2.2M |
Analyst Decision: | Hold | Number of Analysts: | 12 |
Dividend Yield: | 2.25% | Dividend Payout Frequency: | Quarterly |
EPS: | 9.10 | EPS Growth: | 24.83 |
52 Week Low/High: | $69.00 - $91.15 | Next Earning Date: | 07-31-2024 |
Revenue: | $19,336,000,000 | Revenue Growth: | 3.03% |
Revenue Growth (this year): | -4.72% | Revenue Growth (next year): | 0.85% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
LAKE CHARLES D II | AFL | Chairman & Rep. Director, ALIJ | May 21 '24 | Sell | $87.47 | 22,378 | $1,957,426.04 | 61,522 | SEC Form 4 |
MOSKOWITZ JOSEPH L | AFL | Director | May 8 '24 | Sell | $84.84 | 600 | $50,904.00 | 27,550 | SEC Form 4 |
KENNY THOMAS J | AFL | Director | Mar 20 '24 | Sell | $84.62 | 5,000 | $423,105.00 | 17,920 | SEC Form 4 |
RIGGIERI ALBERT | AFL | SVP, Global CRO | Mar 14 '24 | Sell | $83.35 | 8,000 | $666,760.00 | 32,825 | SEC Form 4 |
Collins Arthur Reginald | AFL | Director | Feb 22 '24 | Sell | $79.73 | 3,000 | $239,198.70 | 5,592 | SEC Form 4 |
Koide Masatoshi | AFL | Pres. and Rep. Director, ALIJ | Feb 15 '24 | Sell | $79.91 | 30,493 | $2,436,695.63 | 86,090 | SEC Form 4 |
LAKE CHARLES D II | AFL | Chairman & Rep. Director, ALIJ | Feb 15 '24 | Sell | $79.91 | 32,259 | $2,577,816.69 | 61,522 | SEC Form 4 |
MOSKOWITZ JOSEPH L | AFL | Director | Feb 8 '24 | Sell | $78.63 | 600 | $47,178.00 | 26,010 | SEC Form 4 |
Lloyd Karole | AFL | Director | Feb 6 '24 | Buy | $77.27 | 500 | $38,635.00 | 44,396 | SEC Form 4 |
Lloyd Karole | AFL | Director | Feb 6 '24 | Buy | $77.29 | 500 | $38,645.00 | 44,896 | SEC Form 4 |
BOWERS WILLIAM P | AFL | Director | Feb 5 '24 | Buy | $76.00 | 1,500 | $114,000.00 | 61,817 | SEC Form 4 |
TILLMAN AUDREY B | AFL | Executive Vice President | Feb 2 '24 | Sell | $76.58 | 3,204 | $245,362.32 | 190,362 | SEC Form 4 |
TILLMAN AUDREY B | AFL | Executive Vice President | Feb 2 '24 | Sell | $76.64 | 9,990 | $765,633.60 | 180,372 | SEC Form 4 |
TILLMAN AUDREY B | AFL | Executive Vice President | Feb 2 '24 | Sell | $76.57 | 3,086 | $236,285.76 | 180,372 | SEC Form 4 |
RIMER BARBARA K | AFL | Director | Feb 2 '24 | Sell | $76.41 | 18,210 | $1,391,407.89 | 35,115 | SEC Form 4 |
BEAVER STEVEN KENT | AFL | FSVP, Deputy CFO, Aflac Japan | Dec 1 '23 | Sell | $82.71 | 3,114 | $257,558.94 | 20,914 | SEC Form 4 |
Koide Masatoshi | AFL | Pres. and Rep. Director, ALIJ | Nov 9 '23 | Sell | $80.32 | 32,000 | $2,570,240.00 | 55,598 | SEC Form 4 |
HOWARD JUNE P | AFL | Sr. Vice President | Nov 7 '23 | Sell | $81.01 | 6,000 | $486,078.00 | 123,026 | SEC Form 4 |
BOWERS WILLIAM P | AFL | Director | Nov 2 '23 | Sell | $81.51 | 23,701 | $1,931,868.51 | 60,118 | SEC Form 4 |
AFL Breaking Stock News: Dive into AFL Ticker-Specific Updates for Smart Investing
Benzinga
3 days ago
MT Newswires
3 days ago
PR Newswire
7 days ago
Simply Wall St.
7 days ago
MT Newswires
7 days ago
MT Newswires
7 days ago
PR Newswire
8 days ago
PR Newswire
10 days ago
The information presented on this page, "AFL AFLAC Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.